tiprankstipranks
Advertisement
Advertisement

Smith & Nephew Updates Voting Share Capital and Rights as of 28 February 2026

Story Highlights
  • Smith & Nephew reported 877.7 million issued shares, including treasury holdings, as of 28 February 2026.
  • The company set 849.9 million voting shares as the key denominator for FCA transparency disclosures by investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Smith & Nephew Updates Voting Share Capital and Rights as of 28 February 2026

Meet Samuel – Your Personal Investing Prophet

An announcement from Smith & Nephew Snats ( (SNN) ) is now available.

As of 28 February 2026, Smith & Nephew plc reported total issued share capital of 877,724,845 ordinary shares of US20¢ each, of which 27,835,540 are held in treasury. This leaves 849,889,305 ordinary shares in issue carrying one voting right each.

The company highlighted that shareholders should use the 849,889,305 figure as the denominator when assessing whether they must disclose holdings or changes in holdings under the U.K. Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The clarification, published on 2 March 2026, helps investors accurately track voting rights and ensures compliance with transparency requirements in the London market.

The most recent analyst rating on (SNN) stock is a Hold with a $34.91 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.

Spark’s Take on SNN Stock

According to Spark, TipRanks’ AI Analyst, SNN is a Neutral.

Smith & Nephew Snats’ strong financial performance and positive earnings call are the main drivers of its stock score. However, bearish technical indicators and a high P/E ratio temper the overall outlook. The company’s strategic initiatives, such as the share buyback, reflect confidence in its financial health, but challenges in emerging markets and tariff impacts pose risks.

To see Spark’s full report on SNN stock, click here.

More about Smith & Nephew Snats

Smith & Nephew plc is a U.K.-based medical technology company, best known for manufacturing orthopaedic implants, sports medicine devices and advanced wound management products. It serves hospitals and healthcare providers globally, competing in the broader medtech and surgical solutions market with a focus on improving clinical outcomes and cost efficiency for health systems.

Average Trading Volume: 784,554

Technical Sentiment Signal: Buy

Current Market Cap: $15.66B

See more insights into SNN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1